Elekta AB PE Ratio 2013-2025 | EKTAY
Current and historical p/e ratio for Elekta AB (EKTAY) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Elekta AB PE ratio as of January 23, 2026 is 23.14.
| Elekta AB PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-22 | 6.71 | 95.86 | |
| 2025-10-31 | 4.99 | $0.07 | 71.29 |
| 2025-07-31 | 4.82 | $0.06 | 80.32 |
| 2025-04-30 | 4.94 | $0.05 | 98.89 |
| 2025-01-31 | 5.68 | $0.25 | 22.71 |
| 2024-10-31 | 5.72 | $0.25 | 22.89 |
| 2024-07-31 | 5.89 | $0.28 | 21.03 |
| 2024-04-30 | 6.77 | $0.32 | 21.15 |
| 2024-01-31 | 7.03 | $0.36 | 19.53 |
| 2023-10-31 | 6.27 | $0.33 | 19.00 |
| 2023-07-31 | 7.36 | $0.28 | 26.28 |
| 2023-04-30 | 7.61 | $0.24 | 31.71 |
| 2023-01-31 | 6.46 | $0.22 | 29.38 |
| 2022-10-31 | 4.53 | $0.24 | 18.88 |
| 2022-07-31 | 6.27 | $0.33 | 19.01 |
| 2022-04-30 | 5.96 | $0.35 | 17.04 |
| 2022-01-31 | 8.76 | $0.34 | 25.76 |
| 2021-10-31 | 10.02 | $0.37 | 27.07 |
| 2021-07-31 | 12.47 | $0.36 | 34.64 |
| 2021-04-30 | 11.45 | $0.38 | 30.12 |
| 2021-01-31 | 12.26 | $0.27 | 45.42 |
| 2020-10-31 | 9.93 | $0.26 | 38.21 |
| 2020-07-31 | 8.62 | $0.21 | 41.05 |
| 2020-04-30 | 7.78 | $0.19 | 40.95 |
| 2020-01-31 | 9.55 | $0.34 | 28.09 |
| 2019-10-31 | 11.64 | $0.31 | 37.55 |
| 2019-07-31 | 11.86 | $0.33 | 35.95 |
| 2019-04-30 | 9.80 | $0.34 | 28.81 |
| 2019-01-31 | 10.99 | $0.36 | 30.52 |
| 2018-10-31 | 10.44 | $0.40 | 26.10 |
| 2018-07-31 | 11.49 | $0.40 | 28.72 |
| 2018-04-30 | 9.30 | $0.35 | 26.57 |
| 2018-01-31 | 7.78 | $0.21 | 37.04 |
| 2017-10-31 | 7.81 | $0.12 | 65.08 |
| 2017-07-31 | 7.76 | $0.06 | 129.31 |
| 2017-04-30 | 8.43 | $0.04 | 210.70 |
| 2017-01-31 | 7.17 | $0.03 | 238.85 |
| 2016-10-31 | 6.99 | $0.02 | 349.51 |
| 2016-07-31 | 6.40 | $0.06 | 106.69 |
| 2016-04-30 | 5.87 | $0.04 | 146.73 |
| 2016-01-31 | 5.96 | $0.13 | 45.87 |
| 2015-10-31 | 6.24 | $0.18 | 34.67 |
| 2015-07-31 | 5.31 | $0.19 | 27.93 |
| 2015-04-30 | 7.42 | $0.18 | 41.22 |
| 2015-01-31 | 8.53 | $0.38 | 22.43 |
| 2014-10-31 | 8.11 | $0.39 | 20.80 |
| 2014-07-31 | 9.52 | $0.39 | 24.40 |
| 2014-04-30 | 10.84 | $0.44 | 24.64 |
| 2014-01-31 | 11.33 | $0.47 | 24.10 |
| 2013-10-31 | 11.47 | $0.50 | 22.94 |
| 2013-07-31 | 12.96 | $0.53 | 24.45 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.473B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $240.247B | 28.55 |
| Intuitive Surgical (ISRG) | United States | $188.491B | 72.03 |
| IDEXX Laboratories (IDXX) | United States | $55.181B | 54.80 |
| Edwards Lifesciences (EW) | United States | $49.001B | 32.86 |
| IQVIA Holdings (IQV) | United States | $40.710B | 22.70 |
| Alcon (ALC) | Switzerland | $40.074B | 27.01 |
| Mettler-Toledo (MTD) | United States | $29.378B | 34.37 |
| DexCom (DXCM) | United States | $28.830B | 39.74 |
| STERIS (STE) | Ireland | $25.607B | 26.43 |
| Waters (WAT) | United States | $23.844B | 31.53 |
| Coloplast (CLPBY) | Denmark | $19.494B | 33.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.744B | 0.00 |
| Hologic (HOLX) | United States | $16.742B | 17.59 |
| Penumbra (PEN) | United States | $14.041B | 98.77 |
| Globus Medical (GMED) | United States | $12.667B | 26.58 |
| Masimo (MASI) | United States | $7.731B | 24.77 |
| Glaukos (GKOS) | United States | $7.231B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.112B | 19.42 |
| TransMedics (TMDX) | United States | $4.719B | 55.91 |
| Teleflex (TFX) | United States | $4.644B | 7.40 |
| LivaNova (LIVN) | United Kingdom | $3.488B | 18.84 |
| Veracyte (VCYT) | United States | $3.462B | 39.46 |
| Integer Holdings (ITGR) | United States | $2.997B | 14.07 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| Artivion (AORT) | United States | $2.081B | 95.48 |
| UFP Technologies (UFPT) | United States | $2.057B | 27.15 |
| Nihon Kohden (NHNKY) | Japan | $2.028B | 17.70 |
| PROCEPT BioRobotics (PRCT) | United States | $1.717B | 0.00 |
| AxoGen (AXGN) | United States | $1.476B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.396B | 0.00 |
| IRadimed (IRMD) | United States | $1.322B | 62.96 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.986B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.950B | 5.14 |
| Pacific Biosciences Of California (PACB) | United States | $0.806B | 0.00 |
| SiBone (SIBN) | United States | $0.734B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.78 |
| Alpha Tau Medical (DRTS) | Israel | $0.608B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.608B | 12.13 |
| NeuroPace (NPCE) | United States | $0.568B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.548B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.477B | 13.18 |
| OrthoPediatrics (KIDS) | United States | $0.464B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.438B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 64.59 |
| Sight Sciences (SGHT) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Anteris Technologies Global (AVR) | Australia | $0.271B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.203B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.195B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.135B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.133B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.094B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.74 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |